Cousin H , Abbruzzese G , McCusker C .

DE016289 NIDCR NIH HHS, R01 DE016289 NIDCR NIH HHS

	Fig. 1. ADAM13 knock down in the neural tube does not affect morphant crest migration. (A) Embryos were injected with mRNA encoding GFP alone (Ctl) or together with antisense morpholino for ADAM13 alone (MO13) or ADAM13 and 19 (2MO). The compounds were injected either in one cell at the 2-cell stage (for graft) or in one dorso-animal cell at the 8–16 cell stage (for targeted injection). The graft procedure was carried out at stage 15 and the embryos were scored for their lack of CNC migration at tailbud stage (26–28) for both assays. The pictures show the typical result obtained for each case. The histogram represents the percentage of embryos with no CNC migration normalized to embryos injected with GFP alone and corresponds to the mean of seven (targeted injection) and at least six (graft) independent experiments. The number of embryos scored is as follows. For grafts: Ctl; n=42, MO13; n=25, 2MO; n=61. For targeted injection: Ctl; n=248, MO13; n=258, 2MO; n=281. While 2MO inhibits CNC migration at similar levels for both the grafts and the targeted injection assays, MO13 alone is 5 times more efficient at inhibiting CNC migration in the targeted injection assay than the graft assay. (B) Embryos were injected in one cell at the 2-cell stage with either GFP (Ctl donor), GFP and MO13 (MO13 donor) or RFP and MO13 (MO13 recipient). At stage 15, three types of grafts were performed: 1-GFP expressing CNC were grafted into non-injected embryos (Ctl->NI), 2-GFP+MO13 injected CNC were grafted into non-injected embryos (MO13->NI), 3-GFP+MO13 injected CNC were grafted into embryos injected with RFP+MO13 (MO13->MO13). The pictures show the typical result obtained for each case. The histogram represents the percentage of embryos with no CNC migration normalized to embryos injected with GFP alone and corresponds to the mean of three independent experiments, representing the scoring of 20 embryos for each case. Results show that morphant CNC display a statistically identical level of migration inhibition whether they are grafted into a wild type embryo or a morphant embryo. The error bar represents standard deviation from the mean. ⁎=Statistically different from controls (p<0.05). Arrowheads point to the segments of the CNC. m: mandibular, h: hyoid, b1 and b2: branchial.
	Fig. 2. Manually separating CNC from the surrounding tissue partially rescues CNC migration induced by ADAM13 knock down. (A) Schematics of the experimental procedure. Either GFP mRNA alone, or a mixture of GFP mRNA and ADAM13 morpholino was injected into the dorso-animal cell at the 8-cell stage. At stage 15, embryos were sorted for their expression of GFP and underwent one of the following procedures. 1—The ectoderm was peeled off (ecto peel). 2—The ectoderm was peeled off and the crest lifted away from the underlying mesoderm (ecto+meso peel). 3—The CNC were excised from the embryo and placed back in (autograft). 4—After the procedure, the ectoderm was pulled back on and left to heal. The embryo was left to develop until tailbud stage and scored for their lack of CNC migration. (B) The histogram represents the percentage of embryos with no CNC migration normalized to embryos injected with GFP alone and corresponds to the mean of three independent experiments. As previously reported, ADAM13 KD significantly inhibits CNC migration in the targeted injection assay. The ectoderm peel procedure did not affect this inhibition. However, the ectoderm+mesoderm peel and the autograft procedures rescued CNC migration to levels not statistically different from the GFP control. The number of embryos scored was as follows: GFP; n=159, MO13; n=154, MO13 ecto peel; n=47; MO13; n=45; MO13 autograft; n=43. The error bar represents standard deviation from the mean. ⁎=Statistically different from GFP (p<0.05).
	Fig. 3. ADAM13 function is dispensable for CNC migration in vitro. (A) ADAM13 and 19 knock down has no effect on CNC migration in vitro. Embryos were injected in one cell at the two-cell stage with a mixture of GFP mRNA and either control morpholino (Ctl), ADAM13 morpholino (MO13) or ADAM13 and 19 morpholino (2MO). At stage 15, embryos were sorted and CNC explants placed on fibronectin-coated 96-well plates. For each case, pictures of typical explants are shown before migration (t=0), at the end of the sheet migration phase (t=6 h) and at the end of the single cell migration phase (t=16 h). Morphant CNC cells were capable of migrating in vitro in a pattern indistinguishable from the control CNC. (B) ADAM13 knock down in CNC is efficient and prevents Cadherin-11 cleavage. Twenty CNC were dissected at stage 15 and placed on FN substrate for 2 h before cell surface proteins were biotinylated. Proteins were extracted and immunoprecipitated sequentially using a goat anti-ADAM13 antibody (gA13), the mouse mAb to Cadherin-11 (1B4) and the mouse mAb to integrin β1 (8C8). Both gA13 and 1B4 recognize the cytodomains of ADAM13 and Cadherin-11, respectively. ADAM13 knock down completely abolishes the expression mature ADAM13 at the cell surface (ADAM13, arrowhead). The full length Cadherin-11 protein is still strongly expressed (Cad-11, arrowhead a) but is no longer cleaved (Cad-11, arrowhead b). Integrin α5β1 cell-surface expression is unaffected by ADAM13 knockdown.
	Fig. 4. ADAM13 function is not cell autonomous. Embryos were injected in one cell of two-cell stage embryos with both GFP mRNA and morpholino against ADAM13 and 19 (GFP+2MO) or with RFP mRNA. At stage 15, CNC expressing the lineage tracer were dissected and grafted into non-injected embryos in either one of the following configurations. Either the RFP expressing explant was grafted ventrally to the morphant crest (Wt leader and 2MO follower) or the RFP expressing crest was grafted dorsally to the morphant crest (Wt follower and 2MO leader). Pictures represent a typical example of each type of grafted embryo before (stage 15) and after migration (stage 26). The histogram represents the percentage of failed migration of each type of CNC (Wt or 2MO) for each grafting configuration. Controls (Ctl) correspond to the graft of GFP expressing CNC alone. Student t-tests between the 2MO CNC grafted alone and all other experimental cases were performed. The experiments show that the co-grafting of wild type CNC significantly rescues morphant CNC migration. The configuration of the graft has no impact on the efficiency of the rescue. The co-grafted morphant CNC had no effect on the ability of wild type CNC to migrate. The histogram represents the average of 7 independent experiments. The number of embryos scored was as follows: Ctl; n=42, 2MO alone; n=40, 2MO leader+Wt follower; n=38; 2MO follower+Wt leader; n=33 n=47. The error bar represents standard deviation from the mean. *=Statistically different from 2MO alone (p<0.05).
	Fig. 5. ADAM 13 metalloprotease function is required crest autonomously. Embryos were injected in one cell of 2-cell stage embryos with the following mixture. Donor embryos were injected with RFP as a lineage tracer and either the morpholinos against ADAM13 and 19 alone (2MO) or the two morpholinos plus the mRNA encoding the cytoplasmic domain of ADAM13 (2MO+C13). The recipient embryos were injected with a mixture of GFP and either a form of ADAM13 lacking the cytoplasmic domain (δCyto) or the cleaved form of Cadherin-11 (EC1-3). At stage 15, embryos were sorted for their expression of lineage tracer, CNC explants taken out from donor embryos (RFP, 2MO or 2MO+C13) and grafted into various recipient embryos (NI, δCyto or EC1-3). The embryo was left to develop until tailbud stage and scored for their lack of CNC migration. The histogram represents the percentage of embryos displaying no CNC migration normalized to embryos injected with RFP alone and corresponds to the mean of three independent experiments. Results show that morphant crest migration is not rescued if the metalloprotease activity of ADAM13 is not expressed by the CNC themselves (2MO->δCyto). The expression of the cytodomain of ADAM13 in the morphant crest partially rescues CNC migration (2MO+C13->NI). This partial rescue is not enhanced when these CNC are grafted in embryos expressing δCyto (2MO+C13->δCyto) confirming that ADAM13 can exert its metalloprotease function only when expressed by the CNC. The rescue is complete when the 2MO+C13 CNC are grafted in embryos expressing EC1-3 (2MO+C13->EC1-3). The number of embryos scored was as follows: RFP->NI; n=15, 2MO->NI; n=14, 2MO->δCyto; n=16, 2MO+C13->δCyto; n=15. The error bar represents standard deviation from the mean. *=Statistically different from 2MO->NI (p<0.05).
	Fig. 6. The partial knock down of Cadherin-11 does not rescue CNC migration of ADAM13 morphants. Embryos were injected at the 1 cell stage with either ADAM13 morpholino (MO13 1 ng) alone or together with various doses of morpholino against Cadherin-11 (MOC11) ranging from 5 ng to 25 ng. At stage 20, the proteins of 10 embryos equivalent were extracted, immunoprecipitated with either the cadherin-11 mAb 1B4 or ADAM13 rabbit pAb 6615F and blotted with the cadherin rabbit pAb C11 and the ADAM13 goat pAb 877 respectively. The knock down of ADAM13 alone leads to an increase of the full-length form of Cadherin-11 that can be decreased by a partial cadherin-11 knock down using 5 ng of MOC11. (B) Embryos were injected at the 8-cell stage with either ADAM13 morpholino (MO13 1 ng) alone or together with various doses of morpholino against Cadherin-11 (MOC11) ranging from 1 ng to 5 ng. The mRNA encoding GFP was either co-injected or injected alone as lineage tracer. Embryos were raised until stage 28 and scored for their lack of CNC migration. The histogram represents the percentage of embryos displaying no CNC migration normalized to embryos injected with RFP alone and corresponds to the mean of four independent experiments. The partial knock down of Cadherin-11 with either 1 or 2.5 ng of MOC11 did not significantly rescue the inhibition of CNC migration induced by ADAM13 knock down. The co-injection of 5 ng of MOC11 produced a significantly more severe inhibition than ADAM13 knock down alone. The error bars represent standard deviation from the mean. The number of embryos scored for each case ranged between 207 and 218. *=Statistically different from MO13 (p<0.05).
	Fig. 7. CNC cells can migrate through 20 μm openings. Migration of CNC through small openings. Photographs of explants (10×) taken from time-lapse movies are represented. The width of the obstacle is 200 μm (horizontal arrows) while the opening is 20 μm. Frames from non-injected control (NI) or morphant (MO13) CNC are presented at 0, 3 and 6 h of migration. The arrowhead points to the leading edge of cells migrating in the tunnel. The mask used to obtain the substrates is represented below. The white sections represent the walls of the chambers (200 μm high). Each of the two rectangular chambers has four opening for each of their long side ranging from 15 to 30 μm). The center of the rectangles are filled with SDF-1-coated beads and sealed by covering it with a small coverslip fixed with vacuum grease. Explants are placed with their ventral (leading) edge facing each opening.

Alexander, Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. 2008, Pubmed

Alexander, Dynamic imaging of cancer growth and invasion: a modified skin-fold chamber model. 2008, Pubmed
Alfandari, Mechanism of Xenopus cranial neural crest cell migration. 2010, Pubmed , Xenbase
Alfandari, Integrin alpha5beta1 supports the migration of Xenopus cranial neural crest on fibronectin. 2003, Pubmed , Xenbase
Alfandari, ADAM 13: a novel ADAM expressed in somitic mesoderm and neural crest cells during Xenopus laevis development. 1997, Pubmed , Xenbase
Alfandari, ADAM function in embryogenesis. 2009, Pubmed
Alfandari, Xenopus ADAM 13 is a metalloprotease required for cranial neural crest-cell migration. 2001, Pubmed , Xenbase
Boscher, Cadherin-11 interacts with the FGF receptor and induces neurite outgrowth through associated downstream signalling. 2008, Pubmed
Calvo, Cell communication networks in cancer invasion. 2011, Pubmed
Carmona-Fontaine, Contact inhibition of locomotion in vivo controls neural crest directional migration. 2008, Pubmed , Xenbase
Cousin, Translocation of the cytoplasmic domain of ADAM13 to the nucleus is essential for Calpain8-a expression and cranial neural crest cell migration. 2011, Pubmed , Xenbase
Cousin, PACSIN2 is a regulator of the metalloprotease/disintegrin ADAM13. 2000, Pubmed , Xenbase
Davidson, Integrin alpha5beta1 and fibronectin regulate polarized cell protrusions required for Xenopus convergence and extension. 2006, Pubmed , Xenbase
Epperlein, Analysis of cranial neural crest migratory pathways in axolotl using cell markers and transplantation. 2000, Pubmed
Fowlkes, Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. 1995, Pubmed
Friedl, Cancer invasion and the microenvironment: plasticity and reciprocity. 2011, Pubmed
Gaultier, ADAM13 disintegrin and cysteine-rich domains bind to the second heparin-binding domain of fibronectin. 2002, Pubmed , Xenbase
Gawantka, Beta 1-integrin is a maternal protein that is inserted into all newly formed plasma membranes during early Xenopus embryogenesis. 1992, Pubmed , Xenbase
Giannelli, Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. 1997, Pubmed
Haigo, Global tissue revolutions in a morphogenetic movement controlling elongation. 2011, Pubmed
Hegerfeldt, Collective cell movement in primary melanoma explants: plasticity of cell-cell interaction, beta1-integrin function, and migration strategies. 2002, Pubmed
Ilina, Two-photon laser-generated microtracks in 3D collagen lattices: principles of MMP-dependent and -independent collective cancer cell invasion. 2011, Pubmed
Kashef, Cadherin-11 regulates protrusive activity in Xenopus cranial neural crest cells upstream of Trio and the small GTPases. 2009, Pubmed , Xenbase
Kulesa, Cranial neural crest migration: new rules for an old road. 2010, Pubmed
Latimer, Extracellular matrix assembly and organization during zebrafish gastrulation. 2010, Pubmed
Maretzky, ADAM10 mediates E-cadherin shedding and regulates epithelial cell-cell adhesion, migration, and beta-catenin translocation. 2005, Pubmed
Matthews, Directional migration of neural crest cells in vivo is regulated by Syndecan-4/Rac1 and non-canonical Wnt signaling/RhoA. 2008, Pubmed , Xenbase
Mazzocca, A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions. 2005, Pubmed
McCusker, Extracellular cleavage of cadherin-11 by ADAM metalloproteases is essential for Xenopus cranial neural crest cell migration. 2009, Pubmed , Xenbase
McGinn, Modulation of integrin α4β1 by ADAM28 promotes lymphocyte adhesion and transendothelial migration. 2011, Pubmed
Mechtersheimer, Ectodomain shedding of L1 adhesion molecule promotes cell migration by autocrine binding to integrins. 2001, Pubmed
Minoux, Molecular mechanisms of cranial neural crest cell migration and patterning in craniofacial development. 2010, Pubmed
Najy, The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. 2008, Pubmed
Naus, Ectodomain shedding of the neural recognition molecule CHL1 by the metalloprotease-disintegrin ADAM8 promotes neurite outgrowth and suppresses neuronal cell death. 2004, Pubmed
Neuner, Xenopus ADAM19 is involved in neural, neural crest and muscle development. 2009, Pubmed , Xenbase
Noë, Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. 2001, Pubmed
Paradies, Purification and characterization of NCAD90, a soluble endogenous form of N-cadherin, which is generated by proteolysis during retinal development and retains adhesive and neurite-promoting function. 1993, Pubmed
Reiss, ADAM10 cleavage of N-cadherin and regulation of cell-cell adhesion and beta-catenin nuclear signalling. 2005, Pubmed
Schilling, Plasticity in zebrafish hox expression in the hindbrain and cranial neural crest. 2001, Pubmed , Xenbase
Shoval, Antagonistic roles of full-length N-cadherin and its soluble BMP cleavage product in neural crest delamination. 2007, Pubmed
Smith, The EphA4 and EphB1 receptor tyrosine kinases and ephrin-B2 ligand regulate targeted migration of branchial neural crest cells. 1997, Pubmed , Xenbase
Stamenkovic, Extracellular matrix remodelling: the role of matrix metalloproteinases. 2003, Pubmed
Theveneau, Beads on the run: beads as alternative tools for chemotaxis assays. 2011, Pubmed , Xenbase
Theveneau, Collective cell migration of the cephalic neural crest: the art of integrating information. 2011, Pubmed
Theveneau, Collective chemotaxis requires contact-dependent cell polarity. 2010, Pubmed , Xenbase
Toquet, ADAM15 to α5β1 integrin switch in colon carcinoma cells: a late event in cancer progression associated with tumor dedifferentiation and poor prognosis. 2012, Pubmed
Utton, Soluble N-cadherin stimulates fibroblast growth factor receptor dependent neurite outgrowth and N-cadherin and the fibroblast growth factor receptor co-cluster in cells. 2001, Pubmed
Wei, ADAM13 induces cranial neural crest by cleaving class B Ephrins and regulating Wnt signaling. 2010, Pubmed , Xenbase
Whitelock, The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. 1996, Pubmed
Xu, Proteolytic exposure of a cryptic site within collagen type IV is required for angiogenesis and tumor growth in vivo. 2001, Pubmed
Zamir, The ECM moves during primitive streak formation--computation of ECM versus cellular motion. 2008, Pubmed